Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Children's Hospital, Translational Genomics Research Institute, and University of Arizona.

"Be the change you wish to see in the world..." Gandhi

Our Beneficiaries

  • University of AZ Research Centers
    University of AZ Research Centers
  • “It is every man's obligation to put back into the world at least the equivalent of what he takes out of it.”

    — Albert Einstein

Brain Tumor News

Chemical analysis of blood samples, combined with an artificial intelligence program, could speed up the diagnosis of brain tumours, according to research presented at the 2019 NCRI Cancer Conference. Researchers say their test, which works by detecting chemical clues shed by brain tumours into the blood, could help improve brain tumour survival by making diagnosis quicker and more efficient.

Glioblastoma (GBM) is the type of aggressive brain cancer that took the life of Arizona Senator John McCain in 2018. A notoriously difficult cancer to treat, there have been several high-profile drug failures recently. There’s new hope, however. Researchers at Sweden’s Karolinska Institutet identified 10 potential drug targets for glioblastoma and published the results in the journal Cell Reports.

There is amazing new technology that’s helping surgeons perform the most delicate of all operations.

An adhesive hydrogel that reveals and kills cancer cells could mean the end of debilitating radiation, chemotherapy and surgery for children with brain cancer, a lethal disease that impacts thousands of pediatric patients each year.

Researchers have recently found a compound that can eradicate drug-resistant glioblastoma-initiating cells (GICs). This compound, could potentially be used to eradicate refractory tumors with minimal toxicity.

The combination of advanced imaging and artificial intelligence (AI) could make a brain tumor blood test leading to earlier diagnoses – and perhaps better prognoses, according to new research. Attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy, coupled with machine learning, could differentiate cancer patients and controls with better than 90% sensitivity and specificity.

View Previous News Articles - Click Here!